Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]

BMC Ophthalmology

Volumn 6, Issue , 2006, Pages

  Bahrami, Hossein ^a   Melia, Michele ^a   Dagnelie, Gislin ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; XANTHOPHYLL;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; FEMALE; HUMAN; ILLUMINATION; MALE; MEDICAL LITERATURE; MICROCOMPUTER; RANDOMIZED CONTROLLED TRIAL; RETINITIS PIGMENTOSA; STOMACH DISCOMFORT; VISION TEST; VISUAL ACUITY; VISUAL FIELD; VITAMIN SUPPLEMENTATION; COMPUTER ASSISTED DIAGNOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; VISION;

CONTRAST SENSITIVITY; CROSS-OVER STUDIES; DIAGNOSIS, COMPUTER-ASSISTED; DOUBLE-BLIND METHOD; HUMANS; LUTEIN; MICROCOMPUTERS; RETINITIS PIGMENTOSA; VISION TESTS; VISION, OCULAR; VISUAL ACUITY; VISUAL FIELDS;

EID: 33745996054     PISSN: 14712415     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-6-23     Document Type: Article

References (29)

1. Weleber RG, Gregory-Evans K: Retinitis pigmentosa and allied disorders. Edited by: Ryan SJ. Retina. Mosby, St. Louis; 2001:362-470.
2. Grant CA, Berson EL: Treatable forms of retinitis pigmentosa associated with systemic neurological disorders. Int Ophthalmol Clin 2001, 41(1):103-10.
3. Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W: A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993, 111:761-772.
4. Massof RW, Finkelstein D: Supplemental vitamin A retards loss of ERG amplitude in retinitis pidmentosa. Arch Ophthalmol 1993, 111:751-4.
5. Marmor MF: A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993, 11:1460-1.
6. Clowes DD: A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993, 11:1461-2.
7. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG: A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol 2004, 137(4):704-18.
8. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, Hayes KC, Johnson CA, Anderson EJ, Gaudio AR, Willett WC, Schaefer EJ: Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol 2004, 122(9):1297-305.
9. Semba RD, Dagnelie G: Are lutein and zeaxanthin conditionally essential nutrients for eye health? Med Hypotheses 2003, 61(4):465-72.
10. Hammond BR Jr, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM: Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997, 38:1795-1801.
11. Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell RM: Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000, 71:1555-1562.
12. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO: Factors associated with age-related macular degeneration. An analysis of data from the first national health and nutrition examination survey. Am J Epidemiol 1988, 128:700-710.
13. Eye Disease Case-Control Study Group: Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992, 110:1701-1708.
14. Eye Disease Case-Control Study Group: Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993, 111:104-109.
15. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE: A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 1997, 65:57-62.
16. Dagnelie G, Zorge IS, McDonald TM: Lutein improves visual function in some retinal degeneration patients - a pilot study via Internet. Optometry 2000, 71:147-64.
17. Richer S: Part II. ARMD-pilot (case series) environmental intervention data. J Am Optom Assoc 1999, 70:24-36.
18. Blumberg J, Block G: The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland. Nutr Rev 1994, 52:242-245.
19. Dagnelie G, Melia BM, Sunness JS: Lutein supplementation in RP: Vision measures in the clinic. Invest Ophthalmol Vis Sci 2003:44. #780 [ARVO E-abstract]
20. Dagnelie G: Conversion of planimetric visual field data into solid angles and retinal areas. Clin Vis Sci 1990, 5(1):95-100.
21. Dagnelie G, Yang L, Bahrami H, et al.: Vision tests for the home PC: Test validation and results from a lutein supplementation trial [Abstract]. Journal of Vision 2003, 3(1257a [http://journalofvision.org/3/12/57/]. doi:10.1167/3.12.57
22. Bach M: The Freiburg Visual Acuity test - Automatic measurement of visual acuity. Opt Vis Sci 1996, 73(1):49-53.
23. Piantodosi S: Clinical Trials: A Methodologic Perspective. John Wiley & Sons, New York; 1997.
24. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
25. Massof RW, Dagnelie G, Benzchawel T, Palmer RW, Fikelstein D: First order dynamics of visual field loss in retinitis pigmentosa. Clin Vision Sci 1990, 5:1-26.
26. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D: Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 2000, 41:3322-6.
27. Grover S, Fishman GA, Anderson RJ, Alexander KR, Derlacki DJ: Rate of visual field loss in retinitis pigmentosa. Ophthalmology 1997, 104(3):460-5.
28. Grover S, Fishman GA, Anderson RJ, Tozatti MS, Heckenlively JR, Weleber RG, Edwards AO, Brown J Jr: Visual acuity impairment in Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. Ophthalmology 1999, 106(9):1780-5.
29. Hammond BR Jr, Wooten BR, Snodderly DM: Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 1997, 14(6):1187-96.